Table 2.
Treatments | Dose (kg)−1 | EL (sec) Day-6 | EL (sec) Day-7 | EL (sec) Day-8 | EL (sec) Day-9 |
---|---|---|---|---|---|
Control (vehicle) for 10 days | 10 mL | 105.90 ± 3.28 | 96.34 ± 3.44 | 78.38 ± 3.70 | 54.19 ± 3.44 |
Physostigmine for 10 days | 0.1 mg | 104.31 ± 3.06 |
101.25 ± 2.51 | 74.09 ± 2.45 | 33.5 ±2.66c |
Scopolamine | 0.4 mg | 106.62 ± 18.16 | 87.66 ± 3.75 |
69.63 ± 3.49 | 44.44 ± 2.81b |
Diazepam | 1 mg | 105.96 ± 2.59 | 91.66 ± 2.48 |
69.47 ± 3.21 | 42.56 ± 2.52a |
Palmatine for 10 days | 0.1 mg | 103.93 ± 2.95 | 100.93 ± 3.13 |
78.09 ± 4.01b | 44.22 ± 2.98 |
Palmatine for 10 days | 0.5 mg | 100 ± 3.25 | 88.38 ± 3.84 |
61.56 ± 2.98c | 32.09 ± 2.4b |
Palmatine for 10 days | 1 mg | 99.75 ± 2.80 | 75.43 ± 3.54b | 49.78 ± 2.31 | 26.06 ± 1.54c |
Palmatine for 10 days + scopolamine on 10th day | 1 mg + 0.4 mg | 107.29 ± 3.01 | 83.69 ± 3.48 | 54.75 ± 2.26 | 28.13 ± 1.33d |
Palmatine for 10 days + diazepam on 10th day | 1 mg + 1 mg | 109.90 ± 2.23 | 85.21 ± 2.84 | 55.81 ± 3.39 | 29.91 ± 1.59e |
n = 8. Values are expressed as Mean ± SEM. Data was analyzed by one-way ANOVA followed by Tukey's post-hoc test.
F(8, 279) = 1.264; P = 0.2625 (day 6);
F(8, 279) = 7.147; P < 0.0001 (day 7);
F(8, 279) = 11.079; P < 0.0001 (day 8);
F(8, 279) = 14.251; P < 0.0001 (day 9);
a P < 0.05 as compared to control;
b P < 0.01 as compared to control;
c P < 0.001 as compared to control;
d P < 0.001 as compared to scopolamine treated group;
e P < 0.01 as compared to diazepam treated group.